Fig 1.
Thirty-day mortality rate of patients with Acinetobacter baumannii (Ab) group bacteremia in different susceptibility categories.
The rate was significantly lower in those with carbapenem minimal inhibitory concentration (MIC) ≤ 4 mg/L comparing to those with carbapenem MIC ≥ 8 mg/L.
Fig 2.
Classification and Regression Tree (CART) analysis determined a split of carbapenem minimal inhibitory concentration (MIC) between 4 and 8 mg/L and predicted differences in mortality.
Fig 3.
Comparison of Kaplan–Meier survival curves, at 30 days, between patients with Acinetobacter baumannii group bacteremia caused by isolates having minimal inhibitory concentration (MIC) ≤ 4 mg/L or ≥ 8 mg/L.
Table 1.
Univariate comparison between patients acquiring Acinetobacter baumannii group with carbapenem MIC ≤ 4mg/L and MIC ≥ 8mg/L.
Table 2.
Logistic regression analysis of prognostic factors associated with 30-day mortality among patients treated with carbapenem for Acinetobacter baumannii group bacteremia.
Table 3.
Cox regression analysis of prognostic factors associated with 30-day mortality among patients treated with carbapenem for Acinetobacter baumannii group bacteremia.